Articles about Krishna Ella

05 Jan 2021
IndiaThe first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

05 Jan 2021
IndiaThe Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

04 Jan 2021
IndiaBharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."

03 Jan 2021
IndiaEarlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

23 Sep 2020
TechnologyIn a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.

10 Aug 2020
TechnologyOver the weekend, TikTok was reported to be planning legal action against Trump administration.

04 Aug 2020
IndiaEver since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?

04 Aug 2020
TechnologyNearly two weeks ago, AIIMS Delhi had started the Phase 1 human trial of COVAXIN — the first candidate vaccine developed indigenously in India to fight the spread of COVID-19.

24 Jul 2020
IndiaThe All India Institute of Medical Science (AIIMS) in Delhi has started human trials of COVAXIN, the country's first indigenously developed vaccine to prevent the novel coronavirus disease COVID-19.

17 Jul 2020
IndiaIn the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.

04 Jul 2020
IndiaThe Indian Council of Medical Research (ICMR) on Saturday said that it is acting in accordance with globally-accepted norms by setting a mid-August target for developing a COVID-19 vaccine.